Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials.

Mark C GenoveseGerd R BurmesterOwen HaginoKarthinathan ThangaveluMelitza Iglesias-RodriguezGregory St JohnMiguel A González-GayThomas Mandrup-PoulsenRoy Fleischmann

Published in: Arthritis research & therapy (2020)

ClinTrials.gov NCT01061736: date of registration February 03, 2010; ClinTrials.gov NCT01709578: date of registration October 18, 2012; ClinTrials.gov NCT02332590: date of registration January 07, 2015.

Keyphrases

rheumatoid arthritis
type diabetes
cardiovascular disease
glycemic control
skeletal muscle
systemic sclerosis
binding protein
insulin resistance
idiopathic pulmonary fibrosis